RedShiftBio

See Change™ in Protein Characterization

University of Washington: Characterization of β-amyloid oligomers

Valerie Daggett, Professor of Bioengineering (primary), Biochemistry, Biomedical and Health Informatics, Chemical Engineering, Molecular Engineering, Neuroscience, and Biological Physics, Structure and Design

"We believe it [AQS³pro] can play a significant role in the protein characterization technology toolkit, overcoming shortcomings in existing techniques."

Click here to learn more about how Prof Daggett and others use the AQS³pro to See Change in their proteins and biotherapeutics

Next Generation in Protein Characterization

The AQS³pro launches a new era in IR spectroscopy and protein characterization, bringing repeatable, high sensitivity, automated measurements to every stage of the biopharmaceutical pipeline. Powered by Microfluidic Modulation Spectroscopy (MMS), the AQS³pro measures the secondary structure of proteins over nearly four decades of concentration, from 0.1 mg/ml to over 200 mg/ml. Driven by the industry-leading AQS³delta Analytical Software package, it streamlines and simplifies 5 key measurements:

Aggregation | Quantitation | Stability | Structure | Similarity

See change in your protein, in your workflow, and in your efficiency.

Visit the product page to learn more.

Click Here To Register

Click Here To Register

Load samples and walk away.

The widest concentration range to characterize biotherapeutics.

Generate precise, high sensitivity data.

Analyze and understand protein behavior.

Latest News

RedShiftBio Expands Commercial Team to Support Demand for AQS³pro^TM

RedShiftBio’s AQS3pro Changes the Game in the Detection and Treatment of Alzheimer’s

RedShiftBio Shipping AQS³pro as Industry Endorsements Expand

Photonics Media publishes article on Technological Synergies Move Spectroscopy Out of the Lab

Where you can meet us next

American Drug Delivery and Formulation Summit, Sep 9-10 Boston MA

Structural Biology, Oct 14-16, London UK

Well Characterized Biologics & Biological Assays, Nov 11-13, Reston, VA

MIBio Conference, Nov 13, Cambridge UK

PEGS Europe, Nov 18-22, Lisbon

RedShiftBio™

RedShiftBio™ is an innovative provider of analytical instrumentation for the research, development and manufacturing of protein therapeutic drugs.

Contact Us

RedShift BioAnalytics Inc.

131 Middlesex Turnpike
Burlington, MA 01803

T: 781.345.7300
F: 781-345-7301
E: info@redshiftbio.com

RedShift™, RedShiftBio™, See Change™, and AQS³™ are trademarks of RedShift BioAnalytics, Inc.